Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06376721
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-04-15
Brief Title:
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or RelapsedRefractory NKT-cell Lymphoma
Sponsor:
Organization:
Beijing Tongren Hospital